The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

GJ Ossenkoppele; WJ Graveland; Pieter Sonneveld; SMGJ Daenen; DH Biesma; LF Verdonck; R Schaafsma; PHM Westveer; F Peters; P Noordhuis; P Muus; R van der Holt; M Delforge; Bob Löwenberg; GEG Verhoef

doi:10.1182/blood-2003-07-2195

The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

GJ Ossenkoppele, WJ Graveland, Pieter Sonneveld, SMGJ Daenen, DH Biesma, LF Verdonck, R Schaafsma, PHM Westveer, F Peters, P Noordhuis, P Muus, R van der Holt, M Delforge, Bob Löwenberg, GEG Verhoef

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

100 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2908-2914
Number of pages	7
Journal	Blood
Volume	103
DOIs	https://doi.org/10.1182/blood-2003-07-2195
Publication status	Published - 2004

Research programs

EMC MM-02-41-03

Access to Document

10.1182/blood-2003-07-2195

Cite this

Ossenkoppele, GJ., Graveland, WJ., Sonneveld, P., Daenen, SMGJ., Biesma, DH., Verdonck, LF., Schaafsma, R., Westveer, PHM., Peters, F., Noordhuis, P., Muus, P., van der Holt, R., Delforge, M., Löwenberg, B., & Verhoef, GEG. (2004). The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients. Blood, 103, 2908-2914. https://doi.org/10.1182/blood-2003-07-2195

@article{cac7fa6efc9d4d9abf85b6be63098de2,

title = "The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients",

author = "GJ Ossenkoppele and WJ Graveland and Pieter Sonneveld and SMGJ Daenen and DH Biesma and LF Verdonck and R Schaafsma and PHM Westveer and F Peters and P Noordhuis and P Muus and \{van der Holt\}, R and M Delforge and Bob L{\"o}wenberg and GEG Verhoef",

year = "2004",

doi = "10.1182/blood-2003-07-2195",

language = "Undefined/Unknown",

volume = "103",

pages = "2908--2914",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

}

Ossenkoppele, GJ, Graveland, WJ, Sonneveld, P, Daenen, SMGJ, Biesma, DH, Verdonck, LF, Schaafsma, R, Westveer, PHM, Peters, F, Noordhuis, P, Muus, P, van der Holt, R, Delforge, M, Löwenberg, B & Verhoef, GEG 2004, 'The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients', Blood, vol. 103, pp. 2908-2914. https://doi.org/10.1182/blood-2003-07-2195

TY - JOUR

T1 - The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients

AU - Ossenkoppele, GJ

AU - Graveland, WJ

AU - Sonneveld, Pieter

AU - Daenen, SMGJ

AU - Biesma, DH

AU - Verdonck, LF

AU - Schaafsma, R

AU - Westveer, PHM

AU - Peters, F

AU - Noordhuis, P

AU - Muus, P

AU - van der Holt, R

AU - Delforge, M

AU - Löwenberg, Bob

AU - Verhoef, GEG

PY - 2004

Y1 - 2004

U2 - 10.1182/blood-2003-07-2195

DO - 10.1182/blood-2003-07-2195

M3 - Article

C2 - 15070662

SN - 0006-4971

VL - 103

SP - 2908

EP - 2914

JO - Blood

JF - Blood

ER -